MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib

The c-MYC (MYC afterward) oncogene is well known for driving numerous oncogenic programs. However, MYC can also induce apoptosis and this function of MYC warrants further clarification. We report here that a clinically relevant proteasome inhibitor significantly increases MYC protein levels and that...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirth, Matthias, Stojanovic, Natasa, Christian, Jan, Paul, Mariel C., Stauber, Roland H., Schmid, Roland M., Häcker, Georg, Krämer, Oliver H., Saur, Dieter, Schneider, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Gene regulation, Chromatin and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176343/
https://www.ncbi.nlm.nih.gov/pubmed/25147211
http://dx.doi.org/10.1093/nar/gku763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176343/
https://www.ncbi.nlm.nih.gov/pubmed/25147211
http://dx.doi.org/10.1093/nar/gku763

Ejemplares similares